Our focus on the life sciences
We are an international life sciences investor. Our portfolio includes private and publicly held companies at all stages of development from start-ups to mature enterprises. We leverage our healthcare heritage to provide capital, know-how, and a valuable network to our portfolio companies.
Healthcare
Our teams invest across various healthcare subsectors. We focus on innovative companies developing new or improved medical therapies, or solutions to increase quality, improve efficiency or lower costs in healthcare.
Key figures
Currency
DKK
13
bn
Deployed into life sciences in 2025
300+
Life science investments since 1999
12
New companies added to our Investment Portfolio in 2025
News
05/4/2026
Novo Holdings joins $165 million crossover financing for Windward Bio to advance pipeline of long-acting immunology therapies with best-in-disease potential
Read more
News
04/28/2026
Novo Holdings co-leads $125 million Series A financing in Coultreon Biopharma
Read more
News
04/7/2026
Novo Holdings leads $50 million growth financing in Route 92 Medical
Read more
News
01/30/2026
Novo Holdings Closes Sale of KabaFusion
Read more